ArisGlobal Announces Pharmacovigilance Solution
ArisGlobal, a provider of cloud solutions to life sciences companies, announced it has acquired Medsight Solutions, which includes its integrated risk management solution, Medsight Sapphire.
ArisGlobal, a provider of cloud solutions to life sciences companies, announced it has acquired Medsight Solutions, which includes its integrated risk management solution, Medsight Sapphire. Now known as ArisGlobal agBalance, the solution allows safety experts to directly engage in signal detection and drive the results through signals management into risk management. Regulators and the industry can access the integrated platform for detecting safety issues and communicating the changing benefit-risk profile of medicinal products to the health community in a timely manner. Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
